Business
Ozempic maker Novo Nordisk plunges 22%. What could this mean for Resmed shares?
Image source: Getty Images
When a company sheds over $100 billion of market value in one day, you sit up and pay attention, especially when that company is one of the largest companies in Europe.
Novo Nordisk (NYSE: NVO), the Danish pharmaceutical giant that launched the semaglutide sold under…
Continue Reading
-
Noosa News21 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General22 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General24 hours agoWA shire condemns theft of rip warning sign near Bremer Bay
-
General14 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat